TABAS; Ira

Patent Applications and Registrations

Patent applications and USPTO patent grants for TABAS; Ira.The latest application filed is for "therapeutic targets involved in the progression of nonalcoholic steatohepatitis (nash)".

Company Profile

2.5.9

TABAS; Ira - New City NY
Tabas; Ira - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Targets Involved In The Progression Of Nonalcoholic Steatohepatitis (nash) App 20190255143 - TABAS; Ira ; et al.	2019-08-22
Targeted polymeric inflammation-resolving nanoparticles Grant 10,314,917 - Farokhzad , et al.	2019-06-11
Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors Grant 9,771,430 - Tabas , et al. September 26, 2	2017-09-26
Targeted Polymeric Inflammation-Resolving Nanoparticles App 20160022835 - Farokhzad; Omid C. ; et al.	2016-01-28
CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY App 20140314789 - TABAS; Ira ; et al.	2014-10-23
Visfatin And Uses Thereof App 20090010876 - Tabas; Ira ; et al.	2009-01-08
Phagocyte Enhancement Therapy For Atherosclerosis App 20080267909 - TABAS; Ira	2008-10-30
Methods for preventing acute clinical vascular events in a subject App 20040259853 - Tabas, Ira	2004-12-23
Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase App 20040047851 - Tabas, Ira ; et al.	2004-03-11
Compositions and methods relating to ABCA1-mediated cholesterol efflux App 20030235878 - Tabas, Ira ; et al.	2003-12-25
Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase Grant 6,613,322 - Tabas , et al. September 2, 2	2003-09-02
Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase App 20030026796 - Tabas, Ira ; et al.	2003-02-06
Human gene encoding human chondroitin 6-sulfotransferase Grant 6,399,358 - Williams , et al. June 4, 2	2002-06-04
Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase Grant 5,989,803 - Tabas , et al. November 23, 1	1999-11-23

Company Registrations

NCAGE Code	4QGW5	TABAS IRA
CAGE Code	4QGW5	TABAS, IRA

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.